Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Late Onset Alzheimer's Disease

Columbia University · with National Institute on Aging (NIA) · NCT05010603

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 55+ · All sexes
Healthy volunteers
Accepted
Study type
Observational
Target enrollment
10000
US sites recruiting
12
Study start
November 15, 2016
Record last updated
May 18, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The goal of this study is to is to focus on the genetic influences on Alzheimer's Disease (AD) risk. The investigators are looking for families and/or individuals (affected or unaffected) of any ethic background (African American, Caucasian, and Hispanics) with a family history of AD and willing to participate.

Being studied: Blood Draw; Late Onset Alzheimer's Disease (LOAD) Neuropsychological Battery Test

Conditions: Alzheimer Disease

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Established diagnosis of definite or probable AD or have a diagnosis of a related neurodegenerative disorder such as Frontotemporal Dementia (FTD) or Lewy Body Dementia (LBD) (will also recruit sporadic FTD and LBD) cases.
  • a living sibling with probable or possible AD;
  • a third living relative affected with AD (onset age 50 or older) or unaffected (60 or older);
  • participants in the proband's generation with an identified companion serving as an informant;
  • participants who have capacity to consent or participants lacking capacity to consent with a surrogate/proxy in place to provide consent.

Exclusion Criteria

  • failure to identify an appropriate informant;
  • uncertainty of the clinical diagnosis of Alzheimer's disease or other related disorder;
  • discovery of additional diagnosis that could account for the clinical manifestations;
  • unwillingness to participate;
  • failure to identify a living sibling with AD or other related disorder (except in the cases of sporadic FTD and sporadic LBD);
  • participants lacking the capacity to consent who do not have a surrogate or proxy or next of kin to provide consent.

Recruiting US locations

  • University of Washington

    Washington D.C., DC 98105

    Site contact: Sarah Payne

  • University of Miami

    Miami, FL 33124

    Site contact: Larry Deon

  • Rush University

    Aurora, IL 60612

    Site contact: Corey Woods

  • Indiana University

    Bloomington, IN 47405

    Site contact: Kelly Farber

  • NCRAD at Indiana University

    Indianapolis, IN 46202

    Site contact: Kelly Farber

  • Mayo Clinic

    Rochester, MN 55901

    Site contact: Christine Hanzel

  • Joanne Norton

    St Louis, MO 63130

    Site contact: Joanne Norton

  • Columbia University Irving Medical Center

    New York, NY 10032

    Site contact: Dolly Reyes-Dumeyer · 212-305-5953 · dr2290@cumc.columbia.edu

  • North Carolina State University

    Raleigh, NC 27695

    Site contact: Takiyah Starks

  • University of Pittsburgh

    Pittsburgh, PA 15213

    Site contact: Elise Weamer

  • University of Texas Southwestern

    Dallas, TX 75390

    Site contact: Amy Browning

  • University of Washington

    Seattle, WA 98195

Study contacts (from the official record)

  • Dolly Reyes-Dumeyer · 212-305-5953 · dr2290@cumc.columbia.edu
  • Amanda Chan · 917-696-3082 · akc2177@cumc.columbia.edu
All neurology studies in District of Columbia →
Late Onset Alzheimer's Disease (NCT05010603) | Bored Studies